Telogen effluvium as a symptom of “Long Covid” in patients pre-infected with SARS-CoV-2: an integrative literature review
DOI:
https://doi.org/10.33448/rsd-v11i13.36183Keywords:
COVID-19; SARS-CoV-2; Telogen effluvium.Abstract
COVID-19 is a relatively new disease that presents a broad spectrum of clinical manifestations, among them is telogen effluvium, a condition that promotes diffuse hair loss in the patient, usually after the end of the infection. This article is a narrative literature review that seeks to understand the pathogenesis of telogen effluvium, as well as the impacts of this symptom on patients' lives. For this, a search was carried out in the following databases: National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Virtual Health Library (BVS) and EBSCO Information Services in order to collect the most current information on the topic. Thus, it was noted that telogen effluvium was a complex symptom, as it probably involves more than one mechanism in its pathogenesis. In addition, the study is justified by the effect it has on the self-esteem and self-image of patients who, seeing their hair fall out, have their emotional stress increased. With regard to treatment, correction of the triggering factor, combined with the implementation of a protein-rich diet, proved to be effective in stopping hair loss.
References
Aksou, H. et al. (2021). COVID‐19 induced telogen effluvium. Dermatologic Therapy, 34 (15175).
Alam, M., et al. (2021). Cutaneous manifestations of COVID-19: Characteristics, pathogenesis, and the role of dermatology in the pandemic. Cutis, 107 (4), 209–215.
Araujo, V. C., et al. (2022). Eflúvio Telógeno após a infecção por COVID 19: uma revisão narrativa sobre o mecanismo fisiológico / Telogen Effluvium after SARS-CoV-2 infection: a narrative review of physiological mechanism. Brazilian Journal of Health Review, 5 (3), 10157–10164.
Asghar, F., et al. (2020). Telogen Effluvium: A Review of the Literature. Cureus, 12 (5), 1–7.
Cristina, P., Macedo, Q. D. & Lima, C. (2022). Eflúvio Telógeno Agudo e Alopecia Areata Associada a COVID-19. Brazilian Journal of Health Review, 1 (8), 1–9.
Figueiredo, B. Q., et al. (2021). Mapeamento da “Covid longa ” em pacientes assistidos pela USF Itamarati e previamente infectados por SARS-CoV-2. Research, Society and Development, 12 (1), 1–6.
Fernandes, I. M.,, et al. (2021). Manifestações dermatológicas durante e após a COVID-19: Uma revisão narrativa / Dermatological manifestations during and after Covid-19: A narrative review. Brazilian Journal of Health Review, 4 (5), 20999–21009.
Gabrielle, M. A., et al. (2022). Eflúvio telogeno pós-COVID. Research, Society and Development, 1–7.
Gupta, A. et al. (2020). Extrapulmonary manifestations of COVID-19. Nature medicine, 26 (8), 1017-1032.
Helmy, Y. et al. (2020). The COVID-19 pandemic: a comprehensive review of taxonomy, genetics, epidemiology, diagnosis, treatment, and control. Journal of clinical medicine, 9 (1225).
Hussain, N. et al. (2021). A systematic review of acute telogen effluvium, a harrowing post‐COVID‐ 19 manifestation. Journal of medical virology, 7 (9).
Izumi, M. O. & Brandão, B. J. (2021). Tratamento do Eflúvio Telógeno Pós-Covid 19. BWS Journal, 4 (1), 1–8.
Mieczkowska, K., et al. (2021). Telogen effluvium: a sequela of COVID‐19. International Journal of Dermatology, 6 (8).
Millett, G. A., et al. (2020). Assessing differential impacts of COVID-19 on black communities. Annals of epidemiology, 47 (1), 37-44.
Natário, J. A., et al. (2022). A queda capilar pode ser considerada uma das consequências da COVID-19? Research, Society and Development, 11 (1).
Nykolaichuk, K., et al. (2021). Pós-covid-19 telogen effluvium. Wha tis the razon? InterConf., 6 (2), 302-306.
Olds, H. et al. (2021). Telogen effluvium associated with COVID-19 infection. Dermatologic therapy, 34 (2).
Rivetti, N. & Barruscotti, S. (2020). Management of telogen effluvium during the COVID-19 emergency: Psychological implications. Dermatologic Therapy, 33 (4).
Sharquie, K. E. & Jabbar, R. I. (2021). COVID-19 infection is a major cause of acute telogen effluvium. Irish Journal of Medical Science, 1 (8), 19–23.
Sousa, J. A. B., et al. (2022). Aumento da queda capilar em pessoas acometidas por Sar-Cov2 / Increased hair loss in people affected by Sar-Cov2. Brazilian Journal of Development, 8 (3), 19336–19350.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Bárbara Queiroz de Figueiredo; Ana Flávia de Oliveira Domingos Silva; Gardênia Silva Amorim; Maria Paula Silveira Brito; Priscila Gomes Ribeiro Naves; Renata Teixeira Tajra Melo Boavista; Talita Marques da Silva; Luciana de Almeida França; Yasmin Justine Borges
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
